LAWSUITS NEWS & LEGAL INFORMATION
Search Results for
Sort by relevance 2,441 pages found matching data breach- The FDA Issues Warning for MRI Drug
Jun-18-07 Washington, DC Nephrogenic Systemic Fibrosis (NSF) is a rare condition that can disable or even kill a person unlucky enough to have it. "Patients with NSF experience an increase of collagen in the tissues, causing thickening and hardening of the skin of the extremities and often resulting in immobility and tightening or deformity of the joints," explains... - FDA and The Crisis of China's Poisoned Products
Jun-17-07 Silver Spring, MD Of all defective products you can have, the worst are the ones that you put in your mouth and ingest. Unlike something you swear at when it doesn't work properly, tainted foods and medicines do the damage silently, on the inside. By the time the situation reveals itself, it is often too late. Throughout the last several months there... - Glaxo now faces Lawsuit by Shareholders over Avandia Problems
Jun-16-07 New York, NY GlaxoSmithKline PLC, the maker of the popular diabetes drug Avandia, just can't stay out of the news. And the news is all bad. Since May 21, when a meta-analysis (that is, an analysis of pooled data) of 42 clinical trials involving nearly 28,000 diabetes patients was published, showing that those taking Avandia had a 43% higher risk of... - Mere Weeks after AMO Recall, Lawsuits Start Coming
Jun-14-07 Chicago, IL It didn't take long for lawyer's phones to start ringing after Advanced Medical Optics of Santa Ana, California pulled their stock of AMO Complete MoisturePlus Multi-Purpose Solution from store shelves last month. On June 8th a resident of Santa Clara County, Nicole Lazar, was named as the lead plaintiff on behalf of California consumers who... - Defective Products: Warnings about ATV, CPSC Powerless
Jun-12-07 Stafford, TX Lately, a plethora of defective products have been linked to China - everything from tainted wheat gluten showing up in pet food to diethylene glycol in kiddie toothpaste. (Diethylene glycol, by the way, is a toxic chemical used in the production of anti-freeze.) Given the responsibility manufacturers and marketers carry for the safet... - Taking on Trasylol
Jun-11-07 San Bruno, CA In medicine, some of the most hard-hitting drug research often comes from organizations far removed from the healthcare mainstream. Take the case of Trasylol , for example. Trasylol is the brand name for Aprotinin, a drug approved by the U.S. Food and Drug Administration in 1993 to reduce bleeding during heart surgeries. Trasylol is made... - Bad Faith Insurance: Looking Out for Number One - And it isn't You
Jun-9-07 Beaumont, TX Freddie and Zohreh Shahrodi know all about what their insurance policy SAYS. It's what their insurer didn't deliver that has the Jefferson County couple up in arms, and battling in court—yet another lawsuit against bad faith insurance. According to an article in the Southeast Texas Record the couple's insurer, Fire Insurance Exchan... - Stockbroker Arbitration: Investors Can Recover Their Losses
Jun-8-07 Minneapolis, MN Investors who lose money as the result of improper actions on the part of their stockbroker can get legal help through stockbroker arbitration to recover their losses. Simply losing money on an investment does not mean that an investor has a complaint against a broker. However, if a broker has not acted in the best interests of his cli... - Fireworks on Capitol Hill: FDA on the Defensive, Avandia Warnings Toughened
Jun-7-07 Washington, DC In an obvious attempt to save face, the U.S. Food and Drug Administration (FDA) yesterday announced severely toughened black box warnings for Avandia , and Actos - two diabetes drugs strongly suspected of increasing the risk of heart attack. In front of a packed Congressional hearing yesterday called to investigate the long delays by reg... - Taking Zoloft During Pregnancy Linked to Birth Defects
Jun-7-07 Washington, DC: Less than a year ago, in July 2006, the FDA issued a Public Health Advisory on a birth defect found to be associated with Zoloft and other selective serotonin reuptake inhibitor antidepressants by a study in the February 2006 New England Journal of Medicine that found a higher risk of a life-threatening lung disorder in infants exposed to... - Avandia and FDA now subject of Congressional Hearing
Jun-6-07 Washington, DC Diabetes drug Avandia is making the news again this week, on two fronts. On June 6, 2007 a Congressional committee will hold a meeting to address the safety of Avandia, and the question of whether federal drug regulators (read the FDA) have paid close enough attention to its potential risks. The hearing before the House Committee on Ove... - Avandia Maker Tried to Silence Doctor who had Concerns
Jun-5-07 Washington, DC: A noted diabetes specialist who first raised the red flag on the diabetic drug Avandia in 2000, claims that the drug manufacturer attempted to gag his criticism and quash his findings, to the point where a colleague refused to write prescriptions for Avandia because GlaxoSmithKline was giving his friend such a hard time. Worse, alleged... - Health Advocates Concerned as FDA Approves New Dosage Strength of Fosamax
Jun-4-07 Washington, DC The FDA has approved a new dosage strength of Fosamax Plus D, despite an avalanche of lawsuits related to Fosamax and concerns among health advocates. Hundreds of lawsuits have been filed related to Fosamax, Merck & Co.'s best-selling drug and one of the most prescribed drugs to increase bone density in patients with osteoporosis. "Th... - SSRIs and Birth Defects: More Data Urgently Needed
Jun-1-07 Atlanta, GA There is a problem out there for prospective mothers and fathers. The problem is that instead of being able to find good information on the interplay between SSRIs (a group of antidepressants including Zoloft, Paxil and Prozac) and safe pregnancy, there is a big black void. In its information on medication use during pregnancy and breastfe... - Gardens Manufactured Home Community Breach of Contract Class Action Settlement
Olmsted, OH: (May-30-07) Residents of the Gardens Manufactured Home Community filed a class action lawsuit against the owners in fall 2004, alleging consumer fraud, breach of contract, and violations of state and local laws. The Gardens is east of US 63 at 40th Street Southeast. The development has 129 home sites and opened in 2000. Residents own the manuf... - Battle of Device Maker Shelhigh and FDA Rages On Part I
May-31-07 Newark, NJ: In a New Jersey court hearing on May 15, 2007, US District Court Judge William Martini informed medical device maker Shelhigh that it was unlikely that he will allow the release of any inventory seized by US Marshals at its Union City plant, after the FDA found "significant deficiencies in the company's manufacturing processes." A seizure... - High Anxiety over Avandia Report
May-30-07 Washington, DC Even the United States Senate is getting involved in the worried reaction to the report published last Monday claiming the popular diabetes drug Avandia raises the risk and severity of heart attacks. On May 21 the New England Journal of Medicine reported that an analysis of 42 separate studies on the drug concluded that Avandia rais... - Lawmakers Want to End Big Pharma Recruitment Schemes - Part 1
May-29-07 Washington, DC: Federal lawmakers are stepping up the pace to put a stop to the pharmaceutical industry's customer recruitment schemes used to boost the sale of psychiatric drugs by tugging at heartstrings in promoting mental health screening programs as suicide prevention tools. On May 18, 2007, US House of Representative Ron Paul (R-Texas), a physicia... - Zelnorm Canada: Life Goes on at Novartis
May-27-07 Dorval, PQ In concert with the Food and Drug Administration in the United States (FDA), Health Canada took steps with Novartis Pharmaceuticals to ensure that sales and marketing of Zelnorm have been halted, and pharmacists are going so far as to contact patients in a bid to have the medication returned. In a memorandum to health care professionals d... - Feds Investigate Profits From Off-Label Stent Procedures - Part II
May-25-07 Washington, DC: In addition to the federal investigations into the off-label marketing of drug eluting stents by Boston Scientific and Johnson & Johnson, on May 10, 2007, Rep Maurice Hinchey (D-NY), who serves on the House Appropriations Subcommittee, announced the introduction of the FDA reform bill which addresses the issue of doctors using product...